Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Costa

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
International Urogynecology Journal|September 8, 2010
Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective studyPhilippe Sèbe, Christelle Doucet, Jean-Nicolas Cornu, et al.
Neurourology and Urodynamics|December 16, 2005
Differentiated rabbit prostatic stromal cells in primary culture display functional alpha1A-adrenoceptorsDelphine Boulbès, Armelle Choquet, Stéphanie Barrère-Lemaire, et al.
BJU International|October 19, 2010
Randomized, crossover study evaluating patient preference and the impact on quality of life of urisheaths vs absorbent products in incontinent menEmmanuel Chartier-Kastler, Philippe Ballanger, Jacques Petit, et al.
Neurourology and Urodynamics|February 22, 2018
Impact on quality of life and sexual satisfaction of continent cystostomy with enterocystoplasty in an adult neurologic populationOrnella Lam Van Ba, Laurent Soustelle, Laurent Wagner, et al.
The Journal of Sexual Medicine|October 11, 2011
Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind studyRussell Blair Egerdie, Stephen Auerbach, Claus G Roehrborn, et al.
Presse Medicale (Paris, France : 1983)|September 14, 2006
[Management of urinary tract infections in women. Epidemiologic survey of 7916 women in general practice]François Haab, Pierre Costa, Jean-Claude Colau, et al.
European Urology|November 1, 2011
Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging studyPierre Denys, Loïc Le Normand, Idir Ghout, et al.
Journal of Medical Microbiology|March 9, 2016
Resistance and virulence potential of uropathogenic Escherichia coli strains isolated from patients hospitalized in urology departments: a French prospective multicentre studyJean-Philippe Lavigne, Franck Bruyère, Louis Bernard, et al.
European Urology|June 1, 2005
An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countriesVincenzo Mirone, Pierre Costa, Jan-Erik Damber, et al.
Urology|March 28, 2015
Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled TrialGerald Brock, Francesco Montorsi, Pierre Costa, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
International Urogynecology Journal|September 8, 2010
Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective studyPhilippe Sèbe, Christelle Doucet, Jean-Nicolas Cornu, et al.
Neurourology and Urodynamics|December 16, 2005
Differentiated rabbit prostatic stromal cells in primary culture display functional alpha1A-adrenoceptorsDelphine Boulbès, Armelle Choquet, Stéphanie Barrère-Lemaire, et al.
BJU International|October 19, 2010
Randomized, crossover study evaluating patient preference and the impact on quality of life of urisheaths vs absorbent products in incontinent menEmmanuel Chartier-Kastler, Philippe Ballanger, Jacques Petit, et al.
Neurourology and Urodynamics|February 22, 2018
Impact on quality of life and sexual satisfaction of continent cystostomy with enterocystoplasty in an adult neurologic populationOrnella Lam Van Ba, Laurent Soustelle, Laurent Wagner, et al.
The Journal of Sexual Medicine|October 11, 2011
Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind studyRussell Blair Egerdie, Stephen Auerbach, Claus G Roehrborn, et al.
Presse Medicale (Paris, France : 1983)|September 14, 2006
[Management of urinary tract infections in women. Epidemiologic survey of 7916 women in general practice]François Haab, Pierre Costa, Jean-Claude Colau, et al.
European Urology|November 1, 2011
Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging studyPierre Denys, Loïc Le Normand, Idir Ghout, et al.
Journal of Medical Microbiology|March 9, 2016
Resistance and virulence potential of uropathogenic Escherichia coli strains isolated from patients hospitalized in urology departments: a French prospective multicentre studyJean-Philippe Lavigne, Franck Bruyère, Louis Bernard, et al.
European Urology|June 1, 2005
An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countriesVincenzo Mirone, Pierre Costa, Jan-Erik Damber, et al.
Urology|March 28, 2015
Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled TrialGerald Brock, Francesco Montorsi, Pierre Costa, et al.
Pageof 6